Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

About 10.6 percent of people are left-handed. It is still not well understood why some people prefer to write, draw, and perform other activities with their left hand, while most people prefer to use ...

NATIONAL HARBOR, Md. — Even with dozens or hundreds of sensor satellites in orbit to spot incoming weapons, U.S. military leaders say defending against the most advanced missile threats will require ...

Whenever I give an interview about scientific research on left-handedness, at one point or another, the interviewer will ask the question of what things left-handers have an advantage in over ...

In recent years, the United States has seen an increase in the number of left-wing terrorism attacks and plots, although such violence has risen from very low levels and remains much lower than ...

No matter how hard ideologues try to exclusively blame their political foes for acts of political violence, the truth is that violent extremists today emerge from across the political spectrum. We ...